HomeABTT34 • BVMF
Abbott Laboratories BDR
R$63.14
Jan 31, 2:32:47 PM GMT-3 · BRL · BVMF · Disclaimer
BR listed securityUS headquartered
Previous close
R$63.12
Day range
R$63.14 - R$63.14
Year range
R$43.02 - R$63.82
Market cap
222.60B USD
Avg Volume
375.00
CDP Climate Change Score
B
In the news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
10.97B7.16%
Operating expense
4.07B11.50%
Net income
9.23B478.98%
Net profit margin
84.10440.49%
Earnings per share
1.3412.61%
EBITDA
2.71B-5.54%
Effective tax rate
-354.63%—
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
7.79B6.99%
Total assets
——
Total liabilities
——
Total equity
40.03B—
Shares outstanding
1.75B—
Price to book
2.75—
Return on assets
——
Return on capital
8.67%—
Net change in cash
(USD)Dec 2024Y/Y change
Net income
9.23B478.98%
Cash from operations
——
Cash from investing
——
Cash from financing
——
Net change in cash
——
Free cash flow
——
About
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, in the United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. Wikipedia
Founded
1888
Website
Employees
114,000
Search
Clear search
Close search
Google apps
Main menu